NCT Number: NCT00333853
Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm)
Insulin therapy requires monitoring and frequent review of glucose levels to optimize dosing. Effective presentation and data analysis are essential. We examined HbA1c changes using the OneTouch(R) UltraSmart(R) System (Test Group), an integrated glucose meter and electronic logbook, compared to established meters with paper logbooks (Control Group).
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Diabetes and Endocrine Associates, La Jolla, California, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Male or female subjects with type 1 or type 2 insulin-treated diabetes mellitus with a baseline HbA1c greater than or equal to 8.0%.
- The lower age limit for pediatric subjects was at the discretion of the pediatric investigators and their Institutional Review Board (IRBs).
- The upper age limit for pediatric subjects was 20 years (i.e., not having reached their 21st birthday on date of enrollment).
- Subjects must have monitored blood glucose at least 2 times per day. - Subject's current blood glucose meter has download capability, however, the subject did not routinely use this capability on his/her own.
Exclusion criteria
Treatment and study plan
Primary outcomes
-
Hemoglobin A1c (HbA1c)
Secondary outcomes
-
Measured hypoglycemia
Sponsors and collaborators
Lead sponsor
LifeScan
Industry
Registry information
Official study title
Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm) to Improve Glycemic Control Through Behavioral and Therapeutic Changes
Important dates
- Study start
- 2003
- Study completion
- 2005
- First posted
- Jun 6, 2006
- Registry last updated
- May 13, 2008
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Genetics of Type 2 Diabetes in West Africans
NCT00837122
Cardiovascular Diseases, Diabetes
Accra, Ghana
View Trial DetailsUric Acid Lowering Trial in Youth Onset T2D
NCT03899883
Diabetes, Diabetes Complications
Aurora, Colorado, United States
View Trial DetailsInvestigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes
NCT00065676
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsVitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women
NCT00862433
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial Details